[ad_1]
Sanofi announced on Wednesday that it would sell monthly insulin reserves at a fixed price of $ 99 to cash-paying patients in the United States, while the pharmaceutical giant is facing intense pressure from the US. Trump administration and US Congress to lower the cost of its nearly 100-year life-saving drugs.
Source link
